YD Bio Limited Ordinary Shares (YDES) vs Zura Bio Limited (ZURA)
A side-by-side comparison of YD Bio Limited Ordinary Shares and Zura Bio Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
YDES
YD Bio Limited Ordinary Shares
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZURA
Zura Bio Limited
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — YDES vs ZURA
growth of $100 · dividends reinvested · last 1yYDES -40.9% (-40.9%/yr)ZURA +150.3% (+150.3%/yr)ZURA compounded faster over this window
YDES ZURA
YDES vs ZURA: by the numbers
- •YDES is the larger company ($436M vs $376M market cap).
- •Both run net losses; ZURA's is the smaller (0.00% vs -1392.61% net margin).
Metrics side by side
Valuation
| Metric | YDES | ZURA |
|---|---|---|
| P/B ratio | N/A | 1.91 |
Profitability
| Metric | YDES | ZURA |
|---|---|---|
| Gross margin | -7.06% | 0.00% |
| Operating margin | -883.31% | 0.00% |
| Net margin | -1392.61% | 0.00% |
| ROE | -66.49% | -43.51% |
| ROIC | N/A | -47.06% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.